Although it has been reported that Alexion Pharmaceuticals, one of the few profitable biotechs around, (advised by RBC) is in play on the M&A front, with Biogen (advised by...
The post COVID-19 period, namely from March onwards, has seen a massive re-allocation and indeed, migration by investors between the different sectors. The three big winners have so far...
It appeared that it was rather better to travel than arrive in terms of the latest announcement from biotech group Tiziana Life Sciences (TILS). Fresh news earlier this week...
It would appear that every week we witness a serious multibagger re-rate in a previously unloved minnow. Indeed, some of the biggest risers this year have been and continue...
Although the present Government would apparently not know a COVID test from a driving test, stocks in the COVID space enjoyed a solid start to the week as the...
It is now a couple of weeks since I wrote about the impending furlough crisis and the horrific consequences that lie in wait for unemployment, as well as...
It felt a little like being in the good old days of a proper bull market as far as the announcement from Independent Oil & Gas (IOG) regarding a...
One would have thought that in the current pandemic environment that a company such as Kansas City Southern might be wanting to bite the hand off potential bidders. And...
@ 2020 Zak Mir. All right reserved.